AstriVax NV is a Belgian startup founded in 2022, specializing in innovative vaccine technology. The company is based on research from the Rega Institute at KU Leuven and is located in Haasrode Leuven. AstriVax has developed a unique "Plug and Play" vaccine platform that uses patented DNA-based technology to create self-amplifying live attenuated viruses. These viruses trigger a strong and multi-faceted immune response, making the vaccines highly effective.

AstriVax serves a broad range of clients, including healthcare providers, pharmaceutical companies, and government health agencies. The company operates in the biotechnology and pharmaceutical markets, focusing on both prophylactic (preventive) and therapeutic (treatment) vaccines. This dual approach allows AstriVax to address various infectious diseases and potentially other medical conditions.

The business model of AstriVax revolves around fast-tracking the clinical development of its vaccine candidates. By starting with validated targets, the company aims to quickly bring its vaccines to clinical trials and eventually to market. AstriVax generates revenue through funding rounds, partnerships, and potentially future sales of its vaccines. The recent seed round of 30 million euros, backed by a strong group of investors, underscores the confidence in their technology and business strategy.

AstriVax's leadership team brings extensive experience in the life sciences and biotech industries. CEO Hanne Callewaert has over 15 years of expertise, including roles at Oxurion and GlaxoSmithKline Vaccines. Co-founder Wilfried Dalemans has 35 years of experience and was previously the CTO of TiGenix.

In summary, AstriVax is a promising biotech startup focused on developing groundbreaking vaccines using advanced DNA-based technology. The company aims to revolutionize the vaccine industry by offering highly effective solutions for both prevention and treatment.

Keywords: biotech, vaccines, DNA technology, immune response, clinical development, prophylactic, therapeutic, healthcare, innovation, Belgium.